title: Allogeneic hematopoietic stem cell transplantation for treatment of Gaucher disease.
abstract: Ito and Barrett recently reviewed the international experiences with allogeneic hematopoietic stem cell transplantation (allo-HSCT) for the treatment of the neuronopathic and non-neuronopathic forms of Gaucher disease (GD). In the present communication, the author adds some updated data on the long-term outcome of allo-HSCT for Swedish GD patients with the mean and median follow-up time of 27 years (the longest follow-up of 30 years) and makes comments on some of the authors' statements found in the article.
authors: Maciej
authors: M
authors: Machaczka
mesh_terms: D005776:Gaucher Disease / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans